Filing Flows

Filing Flows › AdaptHealth (AHCO) › Guidance & outlook

AdaptHealth (AHCO) guidance and outlook

AdaptHealth (AHCO) raised some and lowered other parts of its guidance on Nov 3, 2026: Revenue $2.9B for ; EBITDA $510M–$525M for ; Free cash flow $50.0M–$75.0M for . AdaptHealth's 10-Q filed Nov 3, 2026 makes 3 forward-looking statements.

Guidance and outlook

AdaptHealth: what its forward-looking statements are about (10-Q filed 2026-11-03)AdaptHealth: what its forward-looking statements are about (10-Q filed 2026-11-03)Other2Costs1
3 statements; tone +0.00 (−1 all cautious, +1 all confident); 0 hedged.

Latest guidance

MetricPeriodRangeChange
Revenue$2.9Braised
EBITDA$510M–$525Mraised
Free cash flow$50.0M–$75.0Mlowered

From the earnings release filed Nov 3, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Nov 3, 2026

AdaptHealth's latest quarter

AdaptHealth, Q3 2026: revenue $746M (+11% year over year), operating margin -20.9%, net loss $153M, operating cash flow $157M. The chart follows the revenue to costs, profit and cash.

Questions

Did AdaptHealth raise or lower its guidance?

AdaptHealth (AHCO) raised some and lowered other parts of its guidance on Nov 3, 2026: Revenue $2.9B for ; EBITDA $510M–$525M for ; Free cash flow $50.0M–$75.0M for .

What does AdaptHealth expect?

The total costs associated with this plan were $6.1 million, and the Company expects to realize annual savings of approximately $26.8 million as a result of these actions. The Company has also taken steps intended to mitigate the risk of dissemination of the exfiltrated data. The majority of the Company’s income tax receivable relates to federal corporate income tax refunds, which are expected to be received later in 2026.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.